HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lin Zhang Selected Research

2-thioxo-4-thiazolidinecarboxylic acid (TTCA)

11/2014An insertion-deletion polymorphism in interleukin-1α gene associated with susceptibility to preeclampsia.
11/2014[Insertion/deletion polymorphism of IL1A 3'-UTR associated with the susceptibility of prostate cancer ].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lin Zhang Research Topics

Disease

615Neoplasms (Cancer)
11/2022 - 04/2002
119Inflammation (Inflammations)
11/2022 - 03/2006
94Neoplasm Metastasis (Metastasis)
10/2022 - 10/2004
86Infections
09/2022 - 12/2002
80Carcinogenesis
10/2022 - 03/2003
78Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2008
77Breast Neoplasms (Breast Cancer)
10/2022 - 07/2004
70Lung Neoplasms (Lung Cancer)
04/2022 - 11/2003
58Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2022 - 10/2002
53Stomach Neoplasms (Stomach Cancer)
03/2022 - 01/2006
50Hypoxia (Hypoxemia)
10/2022 - 04/2002
45Hepatocellular Carcinoma (Hepatoma)
11/2022 - 03/2006
45Colonic Neoplasms (Colon Cancer)
10/2022 - 11/2003
45Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 04/2002
44Carcinoma (Carcinomatosis)
01/2021 - 01/2002
41Wounds and Injuries (Trauma)
11/2022 - 07/2006
41COVID-19
06/2022 - 01/2020
34Fibrosis (Cirrhosis)
09/2022 - 08/2002
33Heart Failure
02/2022 - 08/2002
32Hypertension (High Blood Pressure)
11/2022 - 08/2002
31Body Weight (Weight, Body)
08/2022 - 12/2007
27Obesity
11/2022 - 01/2012
26Type 2 Diabetes Mellitus (MODY)
03/2022 - 09/2008
25Alzheimer Disease (Alzheimer's Disease)
10/2022 - 10/2008
25Ischemia
09/2022 - 08/2006
24Hemorrhage
05/2022 - 03/2005
23Myocardial Infarction
11/2022 - 07/2005
23Insulin Resistance
03/2022 - 03/2006
23Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 02/2005
23Thrombosis (Thrombus)
01/2022 - 10/2010
20Pneumonia (Pneumonitis)
09/2022 - 12/2005
20Pre-Eclampsia (Preeclampsia)
04/2022 - 01/2012
20Acute Lung Injury
02/2022 - 07/2010
20Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 09/2002
19Prostatic Neoplasms (Prostate Cancer)
01/2022 - 06/2004
17Stroke (Strokes)
10/2022 - 05/2014
17Melanoma (Melanoma, Malignant)
03/2022 - 06/2006
17Atherosclerosis
01/2022 - 02/2006
17Glioma (Gliomas)
01/2022 - 05/2015
17Necrosis
01/2019 - 01/2002
16Parkinson Disease (Parkinson's Disease)
09/2022 - 03/2009
16Reperfusion Injury
06/2022 - 01/2003
16Cognitive Dysfunction
05/2022 - 01/2006
16Esophageal Squamous Cell Carcinoma
01/2022 - 01/2011
16Adenocarcinoma of Lung
01/2022 - 09/2003
15Sepsis (Septicemia)
06/2022 - 11/2013
15Rheumatoid Arthritis
06/2022 - 04/2005
15Pain (Aches)
07/2021 - 06/2008
14Lung Injury
08/2022 - 04/2012

Drug/Important Bio-Agent (IBA)

253Proteins (Proteins, Gene)FDA Link
10/2022 - 04/2002
128Biomarkers (Surrogate Marker)IBA
11/2022 - 07/2004
99MicroRNAs (MicroRNA)IBA
01/2022 - 06/2006
95Pharmaceutical PreparationsIBA
10/2022 - 09/2004
84Messenger RNA (mRNA)IBA
10/2022 - 04/2002
65Biological ProductsIBA
04/2022 - 04/2002
63DNA (Deoxyribonucleic Acid)IBA
12/2021 - 01/2002
60CytokinesIBA
09/2022 - 04/2004
48Glucose (Dextrose)FDA LinkGeneric
06/2022 - 04/2002
41Long Noncoding RNAIBA
09/2022 - 10/2013
40Peptides (Polypeptides)IBA
01/2022 - 08/2002
38RNA (Ribonucleic Acid)IBA
10/2022 - 01/2002
35Small Interfering RNA (siRNA)IBA
10/2022 - 06/2005
33EnzymesIBA
01/2022 - 04/2003
30LigandsIBA
07/2022 - 07/2003
30Therapeutic UsesIBA
02/2022 - 03/2006
29LipidsIBA
05/2022 - 02/2005
28Cisplatin (Platino)FDA LinkGeneric
07/2022 - 04/2004
28Interleukin-6 (Interleukin 6)IBA
05/2022 - 08/2006
27Phosphotransferases (Kinase)IBA
02/2022 - 02/2006
25Insulin (Novolin)FDA Link
04/2022 - 07/2005
24C-Reactive ProteinIBA
03/2022 - 01/2007
24Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2019 - 04/2002
23Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2021 - 03/2006
22AntioxidantsIBA
07/2022 - 02/2005
21Indicators and Reagents (Reagents)IBA
03/2022 - 05/2006
21AutoantibodiesIBA
12/2021 - 08/2002
20AntigensIBA
06/2022 - 08/2002
20CaspasesIBA
08/2021 - 11/2004
19Oxygen (Dioxygen)IBA
11/2022 - 11/2011
19Transcription Factors (Transcription Factor)IBA
01/2022 - 10/2005
18Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 05/2008
18ErbB Receptors (EGF Receptor)IBA
01/2021 - 08/2002
17PhosgeneIBA
01/2022 - 07/2010
17CollagenIBA
01/2022 - 04/2014
16IntegrinsIBA
10/2022 - 02/2009
16ChemokinesIBA
01/2022 - 01/2003
15Caspase 3 (Caspase-3)IBA
05/2022 - 10/2005
15CateninsIBA
01/2022 - 11/2010
15Immune Checkpoint InhibitorsIBA
01/2022 - 04/2018
14Circular RNAIBA
09/2022 - 01/2016
14HydrogelsIBA
08/2022 - 05/2014

Therapy/Procedure

253Therapeutics
12/2022 - 12/2002
78Drug Therapy (Chemotherapy)
07/2022 - 01/2003
30Immunotherapy
06/2022 - 06/2010
26Radiotherapy
04/2022 - 01/2002
22Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 10/2011
20Transplantation
02/2022 - 08/2005
18Lasers (Laser)
06/2022 - 01/2003
17Aftercare (After-Treatment)
06/2022 - 04/2002
16Neoadjuvant Therapy
11/2022 - 04/2004